These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Histocompatibility systems of the mouse. Stimpfling JH Proc Can Cancer Conf; 1969; 8():344-61. PubMed ID: 4893429 [No Abstract] [Full Text] [Related]
11. Immunity in malignant disease. Fairley GH Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160 [No Abstract] [Full Text] [Related]
13. [Induction of specific antitumor immunity in hamsters using cells infected with adenovirus SA7 (C8)]. Babakova SV Vopr Onkol; 1970; 16(6):69-73. PubMed ID: 4322787 [No Abstract] [Full Text] [Related]
14. [Histocompatibility and histocompatibility antigens]. Aizawa M; Itakura K Saishin Igaku; 1968 Jul; 23(7):1321-31. PubMed ID: 4884342 [No Abstract] [Full Text] [Related]
15. [Immunology of tumors]. Surján L Orv Hetil; 1969 Aug; 110(31):1777-82. PubMed ID: 4898067 [No Abstract] [Full Text] [Related]
16. Tumour antigens. Habel K Proc Can Cancer Conf; 1969; 8():390-406. PubMed ID: 4893431 [No Abstract] [Full Text] [Related]
17. [Immunologic reactivity against cancer and possibilities of its change]. Pasternak L; Pasternak G Dermatol Monatsschr; 1970; 156(5):372-7. PubMed ID: 4101547 [No Abstract] [Full Text] [Related]
18. On the mechanisms of tumour facilitation and tumour inhibition. Effect of the local graft-versus-host reaction. Medzihrský J Neoplasma; 1969; 16(1):3-10. PubMed ID: 5815024 [No Abstract] [Full Text] [Related]
19. The activity of cell-free tumour fractions in inducing immunity across a weak histocompatibility barrier. Wolf A Transplantation; 1969 Jan; 7(1):49-58. PubMed ID: 5762195 [No Abstract] [Full Text] [Related]
20. [Aspects of immunotherapy in malignant tumors]. Gericke D Med Klin; 1968 Jul; 63(29):1143-6. PubMed ID: 4976478 [No Abstract] [Full Text] [Related] [Next] [New Search]